fluoxetine has been researched along with guanidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellampalli, SS; Hu, Y; Khanna, R; Kitamura, N; Musharrafieh, R; Tuohy, P; Wang, J; Zhang, J | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
1 review(s) available for fluoxetine and guanidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for fluoxetine and guanidine
| Article | Year |
|---|---|
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68).
Topics: Antiviral Agents; Cell Line, Tumor; Cell Survival; Dibucaine; Drug Design; Enterovirus D, Human; Humans; Quinolines; Structure-Activity Relationship | 2019 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |